Abstract

The value of IgM-enriched immunoglobulin therapy in 44 preterm infants with neonatal sepsis was evaluated in a prospective randomized study. All infants received antibiotic therapy and fresh plasma and / or whole blood transfusions. Twenty randomly-chosen infants were allocated to receive 5 ml / kg / d of IgM-enriched immunoglobulin intravenously for three days. Although the mortality rate in preterm infants whose gestational ages were 31-34 weeks in the immunotherapy group was slightly lower than in the control group, the general mortality rate from sepsis in the control group (9 / 24) and in the immunotherapy group (6 / 20) showed no statistically significant difference (37.5% vs 30.0%, p < 0.05).

Keywords: intravenous immunoglobulin, neonatal sepsis, fresh plasma

How to cite

1.
Erdem G, Yurdakök M, Tekinalp G, Ersoy F. The use of IgM-enriched intravenous immunoglobulin for the treatment of neonatal sepsis in preterm infants. Turk J Pediatr [Internet]. 1993 Dec. 25 [cited 2026 Nov. 20];35(4):277-81. Available from: https://turkjpediatr.org/article/view/3696